These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 582089)

  • 1. Alkaline phosphatase isoenzyme patterns in hyperthyroidism.
    Cooper DS; Kaplan MM; Ridgway EC; Maloof F; Daniels GH
    Ann Intern Med; 1979 Feb; 90(2):164-8. PubMed ID: 582089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
    Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
    Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase bone isoenzyme and osteocalcin in the serum of hyperthyroid cats.
    Archer FJ; Taylor SM
    Can Vet J; 1996 Dec; 37(12):735-9. PubMed ID: 9111692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alkaline phosphatase isoenzymes and hyperthyroidism].
    Hampel R; Weber S; Rose HJ; Meng W; Nilius R
    Z Gesamte Inn Med; 1981 Dec; 36(23):909-13. PubMed ID: 7342516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed mineral metabolism in hyperthyroidism: good correlation with tri-iodothyronine.
    Manicourt D; Demeester-Mirkine N; Brauman H; Corvilain J
    Clin Endocrinol (Oxf); 1979 Apr; 10(4):407-12. PubMed ID: 476975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR; Delmas PD; Malaval L; Tourniaire J
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On thyroid phosphatase in human serum (author's transl)].
    van Husen N; Latzel H; Gerlach U
    Klin Wochenschr; 1976 Apr; 54(8):393-4. PubMed ID: 1271694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroxine and 3,5,3'-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism.
    Laurberg P
    J Clin Endocrinol Metab; 1987 May; 64(5):969-74. PubMed ID: 3558731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G; Karter Y; Aydin S; Uzun H
    Chin J Physiol; 2003 Dec; 46(4):181-6. PubMed ID: 15074839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Glutamyl transpeptidase levels in thyroid disease.
    Azizi F
    Arch Intern Med; 1982 Jan; 142(1):79-81. PubMed ID: 6119059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue sources of serum alkaline phosphatase in 34 hyperthyroid cats: a qualitative and quantitative study.
    Foster DJ; Thoday KL
    Res Vet Sci; 2000 Feb; 68(1):89-94. PubMed ID: 10684764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in hyperthyroidism.
    Kasono K; Sato K; Han DC; Fujii Y; Tsushima T; Shizume K
    Bone Miner; 1988 Sep; 4(4):355-63. PubMed ID: 3191290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J; Kuma K; Mozai T
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
    Sobrinho LG; Limbert ES; Santos MA
    J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
    Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N
    J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.